(Q33933454)

30 July 2017

title

Vaccine delivery to animals (English)

1 reference

30 July 2017

Bowersock TL

1

1 reference

30 July 2017

Martin S

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

Advanced Drug Delivery Reviews

30 July 2017

published in

1 reference

30 July 2017

volume

38

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

167-194

1 reference

Systemic Pasteurella haemolytica infection as a rare sequel to avirulent live Pasteurella haemolytica vaccination in cattle

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

The role of biotechnologically engineered vaccines and diagnostics in pseudorabies (Aujeszky's disease) eradication strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Adjuvants--a classification and review of their modes of action

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

1 reference

7 January 2021

Current status of immunological adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

1 reference

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

A T cell/B cell/epithelial cell internet for mucosal inflammation and immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Efficacy of aluminum hydroxide-adjuvanted Escherichia coli bacterin in turkey poults.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Vaccination of farmed crocodiles (Crocodylus niloticus) against Mycoplasma crocodyli infection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Duration of protective immunity against ovine haemonchosis following vaccination with the nematode gut membrane antigen H11

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Vaccination improves survival of Baltic salmon (Salmo solar) smolts in delayed release sea ranching (net-pen period)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

The iscom structure as an immune-enhancing moiety: experience with viral systems

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus iscoms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

MHC class I antigen processing pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Antigen presentation by MHC class II molecules: invariant chain function, protein trafficking, and the molecular basis of diverse determinant capture

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Ubiquitin-mediated pathways for intracellular proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Influenza virus ISCOMs: antibody response in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Local antibody forming cell responses to the Hitchner B1 and Ulster strains of Newcastle disease virus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Comparison of adjuvants for immune potentiating properties and side effects in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

A type-specific avian influenza virus subunit vaccine for turkeys: induction of protective immunity to challenge infection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Equine herpesvirus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals: prevention of the bifactorial disease with EHV-2 immunostimulating complexes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Delivery of pseudorabies virus envelope antigens enclosed in immunostimulating complexes (ISCOMs); elicitation of neutralizing antibody and lymphoproliferative responses in swine and protection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Evaluation of glycoprotein gII ISCOMs subunit vaccine for pseudorabies in pig

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Characterization of purified gp 51 from bovine leukemia virus integrated into iscom. Physicochemical properties and serum antibody response to the integrated gp51.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Canine distemper virus ISCOMs induce protection in harbour seals (Phoca vitulina) against phocid distemper but still allow subsequent infection with phocid distemper virus-1

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

A novel subunit ISCOM vaccine against bovine virus diarrhoea virus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Protective effect of an ISCOM bovine virus diarrhoea virus (BVDV) vaccine against an experimental BVDV infection in vaccinated and non-vaccinated pregnant ewes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Removal of the cleavage site of recombinant feline immunodeficiency virus envelope protein facilitates incorporation of the surface glycoprotein in immune-stimulating complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Enhancement after feline immunodeficiency virus vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Protective immunity induced in chicken by a single immunization with Mycoplasma gallisepticum immunostimulating complexes (ISCOMS)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Assessment of the immunogenic potential of Rhodococcus equi virulence associated protein (VapA) in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Neospora caninum in dogs: detection of antibodies by ELISA using an iscom antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Intranasal immunization of mice with Echinococcus granulosus surface antigens iscoms evokes a strong immune response, biased towards glucidic epitopes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Immune responses in sheep after immunization with Toxoplasma gondii antigens incorporated into iscoms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Immune responses and resistance to Toxoplasma gondii in mice immunized with antigens of the parasite incorporated into immunostimulating complexes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Biodegradable microspheres as a vaccine delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Use of Vicryl (polyglactin 910) sutures in general surgical and cardiothoracic procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

New methods of drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Biodegradable microparticles with an entrapped branched octameric peptide as a controlled-release HIV-1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Parameters affecting the immunogenicity of microencapsulated tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Protection against vaginal SIV transmission with microencapsulated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Controlled Release of a Luteinizing Hormone-Releasing Hormone Analogue from Poly(d,l-lactide—co-glycolide) Microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Evaluation of antigens of Fasciola gigantica as vaccines against tropical fasciolosis in cattle.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

The intestinal and serum humoral immune response of mice to systemically and orally administered antigens in liposomes: I. The response to liposome-entrapped soluble proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Liposomes as carriers of antigens and adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

The use of immunosome technology for vaccines against rabies and other viral diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Effect of IL-4 and IL-12 liposomal formulations on the induction of immune response to bovine herpesvirus type-1 glycoprotein D

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Efficacy of avridine and liposomes as adjuvants for avian influenza virus antigens in turkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Protection and immunity in commercial chicken layers administered Mycoplasma gallisepticum liposomal bacterins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Sensitivity and specificity of Mycoplasma gallisepticum agglutination antigens prepared from medium with artificial liposomes substituting for serum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Comparison of Mycoplasma gallisepticum subunit and whole organism vaccines containing different adjuvants by western immunoblotting

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Preliminary data on efficacy of Mycoplasma gallisepticum vaccines containing different adjuvants in laying hens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Use of liposome-immunopotentiated exopolysaccharide as a component of an ovine mastitis staphylococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

The intestinal and serum humoral immune response of mice to orally administered antigens in liposomes: II. The response to liposome-entrapped bacterial proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Ascaris suum antigens incorporated into liposomes used to stimulate protection to migrating larvae

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Vaccination of mice with liposome-entrapped adult antigens of Nippostrongylus brasiliensis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Effect of microencapsulation on immunogenicity of a bovine herpes virus glycoprotein and inactivated influenza virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

In vitro activation of human macrophages by alginate-polylysine microcapsules

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Aqueous-based microencapsulation enhances virus-specific humoral immune responses in mice after parenteral inoculation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Microencapsulation of DNA within alginate microspheres and crosslinked chitosan membranes for in vivo application

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Protection of guinea pigs against local and systemic foot-and-mouth disease after administration of synthetic lipid amine (Avridine) liposomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Antigen specificity and activity of ovine antibodies induced by immunization with Corynebacterium pseudotuberculosis culture filtrate

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

The development of effective vaccine adjuvants employing natural regulators of T-cell lymphokine production in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Influence of adjuvants on the immune response of sheep to a novel Staphylococcus aureus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Protective immune response of chickens against Newcastle disease, induced by the intranasal vaccination with inactivated virus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Oral immunization of rabbits against Pasteurella multocida with an alginate microsphere delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Induction of protective immunity in chickens orally immunized with inactivated infectious bursal disease virus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

T cell cytokines and disease prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Influence of recombinant bovine interleukin-1 beta and interleukin-2 in pigs vaccinated and challenged with Streptococcus suis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

The effect of human recombinant interleukin-2 on the porcine immune response to a pseudorabies virus subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

A comparison of antibody responses to veterinary vaccine antigens potentiated by different adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Effect of three commercially available adjuvants on the production of antibodies to Pasteurella multocida in broilers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Studies on the O antigen of Salmonella typhosa. V. Enhancement of antibody response to protein antigens by the purified lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Comparative analysis of the immunostimulatory properties of different adjuvants on the immunogenicity of a prototype parainfluenza virus type 3 subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Oral immunization: turning fantasy into reality

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

The common mucosal immune system and current strategies for induction of immune responses in external secretions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

The mucosal immune system: from fundamental concepts to vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Comparison of vaccination protocols of broiler breeder hens for Pasteurella multocida utilizing enzyme-linked immunosorbent assay and virulent challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

A bovine respiratory virus vaccination trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Recombinant viral vector vaccines for the veterinary use.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Enhancement of in vitro immune responses of murine Peyer's patch cultures by concanavalin A, muramyl dipeptide and lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Induction of a mucosal barrier to bovine herpesvirus 1 replication in cattle

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Selective induction of an immune response in human external secretions by ingestion of bacterial antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Systemic and pulmonary immune response to intrabronchial administration of ovalbumin in calves

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Induction of pulmonary immunity in cattle by oral administration of ovalbumin in alginate microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Orally administered microencapsulated reovirus can bypass suckled, neutralizing maternal antibody that inhibits active immunization of neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

The influence of adjuvants on oral vaccination of chickens against Newcastle disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Comparative antibody responses and protection in mice immunised by oral or parenteral routes with influenza virus subunit antigens in aqueous form or incorporated into ISCOMs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Protection of mice against an influenza virus infection by oral vaccination with viral nucleoprotein incorporated into immunostimulating complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Immune responses and protective effect in mice vaccinated orally with surface sporozoite protein of Eimeria falciformis in ISCOMs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (ISCOM)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Immunization against influenza in humans using an oral enteric-coated killed virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Antigenic characteristics and stability of microencapsulated Mycoplasma hyopneumoniae vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

High antibody titres in mice with polymethylmethacrylate nanoparticles as adjuvant for HIV vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Plant-derived vaccine protects target animals against a viral disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Contribution to rabies prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Disease and fertility control in wildlife and feral animal populations: options for vaccine delivery using vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

1 reference

7 January 2021

Adjuvants of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

1 reference

7 January 2021

A single-step immunization by sustained antigen release

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Delivery of proteins from a controlled release injectable implant

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Applications of pox virus vectors to vaccination: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Role of glycoprotein gD in the adhesion of pseudorabies virus infected cells and subsequent cell-associated virus spread

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Glycoprotein gH of pseudorabies virus is essential for penetration and propagation in cell culture and in the nervous system of mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Selection of bacterial virulence genes that are specifically induced in host tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Simultaneous identification of bacterial virulence genes by negative selection.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Naked DNA transport and expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Cytokine gene expression in epidermis with biological effects following injection of naked DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Long-term expression of a fluorescent reporter gene via direct injection of plasmid vector into mouse skeletal muscle: comparison of human creatine kinase and CMV promoter expression levels in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

Nucleic acid immunization protects dogs against challenge with virulent canine parvovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2899%2900015-0

7 January 2021

10.1016/S0169-409X(99)00015-0

Identifiers

DOI

1 reference

30 July 2017

1 reference